Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 15
Phase 21

Trial Status

Completed3
Terminated2
Other1

Role Distribution

Principal Investigator6
PI Rate100%

Activity Timeline

Clinical Trials (6)

NCT05038839Phase 1Completed
Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors
Advanced Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm
PrincipalinvestigatorStart date: 2022-02-09
NCT05075993Phase 1Active Not Recruiting
Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors
Gastric CancerMetastatic EsophagealMetastatic Head and Neck Carcinoma+5 more
PrincipalinvestigatorStart date: 2021-11-12
NCT05036681Phase 2Terminated
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma
Endometrial CarcinomaEndometrium CancerMetastatic Cancer
PrincipalinvestigatorStart date: 2021-09-30
NCT03203525Phase 1Terminated
Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer
Advanced Malignant NeoplasmColorectal Carcinoma Metastatic in the LiverMetastatic Malignant Neoplasm in the Liver+1 more
PrincipalinvestigatorStart date: 2020-06-23
NCT03784677Phase 1Completed
A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors
Advanced Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmRefractory Ovarian Carcinoma+20 more
PrincipalinvestigatorStart date: 2019-07-29
NCT03756818Phase 1Completed
TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors
Advanced Malignant Solid NeoplasmOvarian CarcinomaRefractory Malignant Solid Neoplasm+1 more
PrincipalinvestigatorStart date: 2019-03-05

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Rahul Aggarwal, MD

University of California, San Francisco

Related
22 trials

Shared therapeutic areas:

Stage IVB Prostate Cancer AJCC v8Endometrial CarcinomaStage IV Prostate Cancer AJCC v8+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Cancer of StomachAdvanced Malignant Solid NeoplasmMetastatic Cancer

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Aung Naing, Md

M.D. Anderson Cancer Center

Related
16 trials

Shared therapeutic areas:

Advanced Malignant Solid NeoplasmMetastatic CancerOvarian Carcinoma

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score2%

Jane Robertson, BSc, MBCHB, MD

AstraZeneca

Related
12 trials

Shared therapeutic areas:

Cancer of StomachOvarian Carcinoma
Similarity Score2%

Lei Li, M.D.

Peking Union Medical College Hospital

Related
46 trials

Shared therapeutic areas:

Endometrial CarcinomaOvarian Carcinoma
Similarity Score2%

Steven R. Alberts, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

Metastatic CancerCancer of Stomach

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Cancer of StomachAdvanced Malignant Neoplasm
Similarity Score2%

James L Gulley, M.D.

National Cancer Institute (NCI)

Related
18 trials

Shared therapeutic areas:

Metastatic CancerMetastatic Hepatocellular Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score2%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Endometrial CarcinomaCancer of Stomach
Similarity Score2%

Herui Yao, PhD

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Related
11 trials

Shared therapeutic areas:

Cancer of Stomach
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (6)

Showing 6 of 6 trials

NCT05038839Phase 1PrincipalInvestigator

Cabozantinib and Pamiparib for the Treatment of Advanced of Refractory Solid Tumors

Advanced Malignant Solid NeoplasmRefractory Malignant Solid Neoplasm
Completed
NCT05075993Phase 1PrincipalInvestigator

Study of LVGN3616 and LVGN6051±LVGN7409 in Combination With Nab-Paclitaxel or Bevacizumab and Cyclophosphamide in Metastatic Solid Tumors

Gastric CancerMetastatic EsophagealMetastatic Head and Neck Carcinoma+5 more
Active Not Recruiting
NCT05036681Phase 2PrincipalInvestigator

A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma

Endometrial CarcinomaEndometrium CancerMetastatic Cancer
Terminated
NCT03203525Phase 1PrincipalInvestigator

Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

Advanced Malignant NeoplasmColorectal Carcinoma Metastatic in the LiverMetastatic Malignant Neoplasm in the Liver+1 more
Terminated
NCT03784677Phase 1PrincipalInvestigator

A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumors

Advanced Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmRefractory Ovarian Carcinoma+20 more
Completed
NCT03756818Phase 1PrincipalInvestigator

TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors

Advanced Malignant Solid NeoplasmOvarian CarcinomaRefractory Malignant Solid Neoplasm+1 more
Completed

All 6 trials loaded